FesariusTherapeutics: Series ADevelops FDA-cleared hydrogel dermal regeneration templates for wound healing and reconstructive surgeryOct 4, 2026RoundOSFesariusTherapeuticsCompany profile and funding historySourcesprnewswire.comMore in HealthtechMetriport · Series AProFound Therapeutics · StrategicArintra · Series BBiotechUnited StatesHealthtechNorth AmericaSeries A